Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
01/25/1996 | WO1996001652A1 Aqueous risperidone formulations |
01/25/1996 | WO1996001650A1 A conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate |
01/25/1996 | WO1996001637A1 New pharmaceutical preparation for pain management |
01/25/1996 | WO1996001634A1 Long-acting oxytetracycline composition |
01/25/1996 | WO1996001628A1 Pharmaceutical composition for the controlled release of moguisteine in a liquid suspension |
01/25/1996 | WO1996001626A1 Transdermal drug delivery system |
01/25/1996 | WO1996001623A1 Multiple unit tableted dosage form i |
01/25/1996 | WO1996001570A1 Cold water-dispersible compositions of fat-soluble active substances |
01/25/1996 | WO1996001558A1 Anandamide analogue compositions and method of treating intraocular hypertention using same |
01/25/1996 | DE4426709A1 Steroidale Sexualhormone enthaltende feste Arzneiformen Sex steroid-containing solid dosage forms |
01/25/1996 | DE4425322A1 Virostatics in a hydrophobic base for topical use |
01/25/1996 | CA2194796A1 Cold water-dispersible compositions of fat-soluble active substances |
01/25/1996 | CA2194460A1 Melt-processible poly(ester urethane) and a process for the preparation thereof |
01/25/1996 | CA2194374A1 Pharmaceutical composition for the controlled release of moguisteine in a liquid suspension |
01/25/1996 | CA2193992A1 New pharmaceutical preparation for pain management |
01/25/1996 | CA2193263A1 Adenovirus comprising a gene coding for an no synthase |
01/24/1996 | EP0693284A1 Prostacyclin-containing oleaginous ointment |
01/24/1996 | EP0693282A2 Duloxetine enteric pellets |
01/24/1996 | EP0693281A2 Fluoxetine Pharmaceutical formulations |
01/24/1996 | EP0693130A1 Targeted delivery of genes encoding antisense polyribonucleotides |
01/24/1996 | EP0693079A1 Derivatives of triterpenoid acids and uses thereof |
01/24/1996 | EP0631617A4 Colon crypt cell mitogen, cell line producing it, and uses thereof. |
01/24/1996 | CN1115564A Polymer-bound camptothecin derivatives |
01/24/1996 | CN1115252A Ionic molecular conjugates of biodergaable polyesters and bioactive polypeptides |
01/23/1996 | US5486623 Cysteine protease inhibitors containing heterocyclic leaving groups |
01/23/1996 | US5486537 Cinnamic aldehyde, griseofluvin, alcohol |
01/23/1996 | US5486508 Cyclodextrin composition |
01/23/1996 | US5486507 Porous particle aggregate and method therefor |
01/23/1996 | US5486365 Calcium hydrogen phosphate, a method for preparing it, and an excipient utilizing it |
01/23/1996 | US5486364 Readily available konjac glucomannan as a sustained release excipient |
01/23/1996 | CA1337970C Antibacterial adhesive composition |
01/18/1996 | WO1996001129A1 Inclusion complexes of ranitidine |
01/18/1996 | WO1996001128A2 Low-dose steroid tablets containing gallic acid esters as antioxidant agent, process for the manufacture of said tablets, and uses of said tablets |
01/18/1996 | WO1996001119A1 Antimicrobial compositions useful for medical applications |
01/18/1996 | WO1996001112A1 Carbamazepine medicament with retarded active substance release |
01/18/1996 | WO1996001102A1 Factor to grow tissue ex vivo |
01/18/1996 | WO1995034302A3 Method for reducing intraocular pressure in the mammalian eye by administration of calcium chelators |
01/18/1996 | DE4424085A1 Kaltwasserdispergierbare Zubereitungen fettlöslicher Wirkstoffe Kaltwasserdispergierbare preparations of fat-soluble substances |
01/18/1996 | CA2194371A1 Low-dose steroid tablets containing gallic acid esters as antioxidant agent, process for the manufacture of said tablets, and uses of said tablets |
01/18/1996 | CA2194216A1 Carbamazepine medicament with retarded active substance release |
01/18/1996 | CA2194057A1 Factor to grow tissue ex vivo |
01/17/1996 | EP0692506A2 Thermo-sensitive polyether polyurethane, production method thereof and thermo-sensitive composition |
01/17/1996 | EP0692255A2 Antacid preparation with improved safety profile |
01/17/1996 | EP0692249A1 Compounds bearing one or more oxime functions, stabilized in aqueous solution, process to prepare them, and their use as drugs |
01/17/1996 | EP0692242A1 Use of deformable hollow particles in a cosmetic and/or dermatological composition containing fatty substance |
01/17/1996 | EP0692241A1 Gelified, rich in solvent cosmetic and/or dermatological composition containing hollow particles |
01/17/1996 | EP0692096A1 Determination of concentration by affinity titration and competitive displacement in drug delivery |
01/17/1996 | EP0692029A1 Genetically engineered glutaminase and its use in antiviral and anticancer therapy |
01/17/1996 | EP0691992A1 Random block copolymers |
01/17/1996 | EP0691990A1 Amphoteric copolymer derived from vinylpyridine & acetoxystyrene |
01/17/1996 | EP0691976A1 Anticoagulant compounds |
01/17/1996 | EP0691886A1 Microcapsules with walls made of cross-linked plant polyphenols, and compositions containing same |
01/17/1996 | EP0691854A1 Conjugates of proteins and bifunctional ligands |
01/17/1996 | EP0691852A1 Prodrugs with enhanced penetration into cells |
01/17/1996 | EP0691844A1 Method for treating amyloidosis |
01/17/1996 | EP0691828A1 Method of detecting compounds utilizing chemically modified lambdoid bacteriophage |
01/17/1996 | EP0674646A4 Lipid derivatives of phosphonoacids for liposomal incorporation and method of use. |
01/17/1996 | EP0577659B1 Cross-linking agent |
01/17/1996 | EP0522128B1 Water-dispersible tablets |
01/17/1996 | CN1114903A A styrene-isoprene-styrene copolymer-based transdermal matrix system for the administration of an oestrogen and/or a progestogen |
01/17/1996 | CN1114879A Method of administering azithromycin |
01/16/1996 | US5484913 Surgical equipment |
01/16/1996 | US5484907 Nucleotides coding for the extracellular membrane-bound segment of IgA |
01/16/1996 | US5484893 Tri-aza macrocycles and metal complexes thereof |
01/16/1996 | US5484816 Stabilized vitamin a composition |
01/16/1996 | US5484809 Prodrugs for oral administration containing taxol or substituted taxol covalently bound to a phospholipid |
01/16/1996 | US5484801 Pharmaceutical composition for inhibiting HIV protease |
01/16/1996 | US5484776 Process for the production of stable liquid form of beta-blocker-containing medicaments with controlled release of the active constituent for oral administration |
01/16/1996 | US5484773 Treatment of antibiotic associated diarrhea |
01/16/1996 | US5484704 Screening tissues for cancer cells |
01/16/1996 | US5484606 Stability |
01/16/1996 | US5484584 Therapeutic and diagnostic use of modified polymeric microcapsules |
01/16/1996 | CA2074454C Medicine based on neutralized sulphur derivatives |
01/16/1996 | CA2017281C Modified polyester composition and preparation process and use thereof |
01/14/1996 | CA2153567A1 Antacid formulation having an improved safety profile |
01/14/1996 | CA2153553A1 Stable lipid emulsion |
01/11/1996 | WO1996000792A1 Use of a bacterial component to enhance targeted delivery of polynucleotides to cells |
01/11/1996 | WO1996000783A1 Antibodies which bind to insect gut proteins and their use |
01/11/1996 | WO1996000760A1 pH-MODIFIED BIOCOMPATIBLE MONOMER AND POLYMER COMPOSITIONS |
01/11/1996 | WO1996000585A1 Diphosphate or triphosphate analogue conjugates |
01/11/1996 | WO1996000567A1 Butylene oxide-ethylene oxide block copolymer surfactants as stabilizer coatings for nanocrystal formulation |
01/11/1996 | WO1996000537A1 Microcapsules for administration of neuroactive agents |
01/11/1996 | WO1996000506A1 Stabilized composition comprising colistin sulfate |
01/11/1996 | WO1996000503A1 Novel peptides |
01/11/1996 | CA2193968A1 Ph-modified biocompatible monomer and polymer compositions |
01/11/1996 | CA2193859A1 Antibodies which bind to insect gut proteins and their use |
01/11/1996 | CA2192957A1 Semenogelin-derived oligopeptides cleavable by prostate specific antigen |
01/10/1996 | EP0691407A1 Non-reducing saccharide and its production and use |
01/10/1996 | EP0691344A1 Purification of trehalose |
01/10/1996 | EP0690722A1 Composition and method for reducing toxicity of biologically-active factors |
01/10/1996 | EP0690719A1 Dry mix formulation for bisphosphonic acids |
01/10/1996 | EP0656026A4 Polyarylates containing derivatives of the natural amino acid l-tyrosine. |
01/10/1996 | EP0630236B1 Self-assembling diketopiperazine drug delivery system |
01/10/1996 | EP0610441A4 Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release. |
01/10/1996 | EP0609321B1 Stabilized calorific nutrient solution and multi-chamber system for the parenteral feeding of humans |
01/10/1996 | EP0605578B1 Pressurised aerosol compositions |
01/10/1996 | EP0599850B1 Composition and method for treating cystic fibrosis |
01/10/1996 | EP0527946B1 Controlled release vehicle |
01/10/1996 | EP0471084B1 Oil-in-water emulsion composition containing nonsteroidal antiphlogistic analgesic |
01/10/1996 | CN1114824A 1 alpha, 24-(OH)2-vitamin D3 emulsion composition |